Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Rosiglitazone on Body Fat Distribution in Type 2 Diabetes
NCT01045590Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2003
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Dec 2003; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01045590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01045590.